2026-2031 Global Opioid-Induced Constipation Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
HNY Research projects that the Opioid-Induced Constipation market size will grow from 2822.34 Million USD in 2025 to 3824.08 Million USD by 2031, at an estimated CAGR of 5.19%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 610.19 Million USD, the Europe market size was 559.67 Million USD, and the Asia market size was 502.38 Million USD.
This report presents a detailed and holistic analysis of the global Opioid-Induced Constipation market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Opioid-Induced Constipation manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
By Type
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
By Application
Hospital
Pharmacy
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
For 2025 regional market size, the North America market size was 610.19 Million USD, the Europe market size was 559.67 Million USD, and the Asia market size was 502.38 Million USD.
This report presents a detailed and holistic analysis of the global Opioid-Induced Constipation market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Opioid-Induced Constipation manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
By Type
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
By Application
Hospital
Pharmacy
Other
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
- The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
- To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the market.
- Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid-Induced Constipation Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type: 2026-2031
1.4.2 Methylnaltrexone Bromide
1.4.3 Lubiprostone
1.4.4 Naloxegol
1.4.5 Others
1.5 Market by Application
1.5.1 Global Opioid-Induced Constipation Market Share by Application: 2026-2031
1.5.2 Hospital
1.5.3 Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Overview of Global Opioid-Induced Constipation Market
1.7.1 Global Opioid-Induced Constipation Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Opioid-Induced Constipation
2.2 Industry Chain Structure of Opioid-Induced Constipation
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Opioid-Induced Constipation Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Opioid-Induced Constipation Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Opioid-Induced Constipation Average Price by Manufacturers (2020-2025)
4 OPIOID-INDUCED CONSTIPATION REGIONAL MARKET ANALYSIS
4.1 Opioid-Induced Constipation Production by Regions
4.1.1 Global Opioid-Induced Constipation Production by Regions (2020-2025)
4.1.2 Global Opioid-Induced Constipation Revenue by Regions
4.2 Opioid-Induced Constipation Consumption by Regions
4.3 North America Opioid-Induced Constipation Market Analysis
4.3.1 North America Opioid-Induced Constipation Production
4.3.2 North America Opioid-Induced Constipation Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Opioid-Induced Constipation Import and Export
4.4 East Asia Opioid-Induced Constipation Market Analysis
4.4.1 East Asia Opioid-Induced Constipation Production
4.4.2 East Asia Opioid-Induced Constipation Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Opioid-Induced Constipation Import & Export
4.5 Europe Opioid-Induced Constipation Market Analysis
4.5.1 Europe Opioid-Induced Constipation Production
4.5.2 Europe Opioid-Induced Constipation Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Opioid-Induced Constipation Import & Export
4.6 South Asia Opioid-Induced Constipation Market Analysis
4.6.1 South Asia Opioid-Induced Constipation Production
4.6.2 South Asia Opioid-Induced Constipation Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Opioid-Induced Constipation Import & Export
4.7 Southeast Asia Opioid-Induced Constipation Market Analysis
4.7.1 Southeast Asia Opioid-Induced Constipation Production
4.7.2 Southeast Asia Opioid-Induced Constipation Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Opioid-Induced Constipation Import & Export
4.8 Middle East Opioid-Induced Constipation Market Analysis
4.8.1 Middle East Opioid-Induced Constipation Production
4.8.2 Middle East Opioid-Induced Constipation Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Opioid-Induced Constipation Import & Export
4.9 Africa Opioid-Induced Constipation Market Analysis
4.9.1 Africa Opioid-Induced Constipation Production
4.9.2 Africa Opioid-Induced Constipation Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Opioid-Induced Constipation Import & Export
4.10 Oceania Opioid-Induced Constipation Market Analysis
4.10.1 Oceania Opioid-Induced Constipation Production
4.10.2 Oceania Opioid-Induced Constipation Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Opioid-Induced Constipation Import & Export
4.11 South America Opioid-Induced Constipation Market Analysis
4.11.1 South America Opioid-Induced Constipation Production
4.11.2 South America Opioid-Induced Constipation Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Opioid-Induced Constipation Import & Export
5 OPIOID-INDUCED CONSTIPATION SALES MARKET BY TYPE (2020-2031)
5.1 Global Opioid-Induced Constipation Historic Market Size by Type (2020-2025)
5.2 Global Opioid-Induced Constipation Forecasted Market Size by Type (2026-2031)
6 OPIOID-INDUCED CONSTIPATION CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Opioid-Induced Constipation Historic Market Size by Application (2020-2025)
6.2 Global Opioid-Induced Constipation Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN OPIOID-INDUCED CONSTIPATION BUSINESS
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Company Profile
7.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
7.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Bayer
7.2.1 Bayer Company Profile
7.2.2 Bayer Opioid-Induced Constipation Product Specification
7.2.3 Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Sanofi
7.3.1 Sanofi Company Profile
7.3.2 Sanofi Opioid-Induced Constipation Product Specification
7.3.3 Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Mallinckrodt
7.4.1 Mallinckrodt Company Profile
7.4.2 Mallinckrodt Opioid-Induced Constipation Product Specification
7.4.3 Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Salix (Bausch Health)
7.5.1 Salix (Bausch Health) Company Profile
7.5.2 Salix (Bausch Health) Opioid-Induced Constipation Product Specification
7.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 AstraZeneca
7.6.1 AstraZeneca Company Profile
7.6.2 AstraZeneca Opioid-Induced Constipation Product Specification
7.6.3 AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Progenics Pharmaceuticals
7.7.1 Progenics Pharmaceuticals Company Profile
7.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
7.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Purdue Pharm
7.8.1 Purdue Pharm Company Profile
7.8.2 Purdue Pharm Opioid-Induced Constipation Product Specification
7.8.3 Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Nektar Therapeutics
7.9.1 Nektar Therapeutics Company Profile
7.9.2 Nektar Therapeutics Opioid-Induced Constipation Product Specification
7.9.3 Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Company Profile
7.10.2 Daiichi Sankyo Opioid-Induced Constipation Product Specification
7.10.3 Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Prestige
7.11.1 Prestige Company Profile
7.11.2 Prestige Opioid-Induced Constipation Product Specification
7.11.3 Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 GSK
7.12.1 GSK Company Profile
7.12.2 GSK Opioid-Induced Constipation Product Specification
7.12.3 GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 Shionogi
7.13.1 Shionogi Company Profile
7.13.2 Shionogi Opioid-Induced Constipation Product Specification
7.13.3 Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Opioid-Induced Constipation (2026-2031)
8.2 Global Forecasted Revenue of Opioid-Induced Constipation (2026-2031)
8.3 Global Forecasted Price of Opioid-Induced Constipation (2020-2031)
8.4 Global Forecasted Production of Opioid-Induced Constipation by Region (2026-2031)
8.4.1 North America Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.3 Europe Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.7 Africa Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.9 South America Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Opioid-Induced Constipation by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Opioid-Induced Constipation by Country
9.2 East Asia Market Forecasted Consumption of Opioid-Induced Constipation by Country
9.3 Europe Market Forecasted Consumption of Opioid-Induced Constipation by Countriy
9.4 South Asia Forecasted Consumption of Opioid-Induced Constipation by Country
9.5 Southeast Asia Forecasted Consumption of Opioid-Induced Constipation by Country
9.6 Middle East Forecasted Consumption of Opioid-Induced Constipation by Country
9.7 Africa Forecasted Consumption of Opioid-Induced Constipation by Country
9.8 Oceania Forecasted Consumption of Opioid-Induced Constipation by Country
9.9 South America Forecasted Consumption of Opioid-Induced Constipation by Country
9.10 Rest of the world Forecasted Consumption of Opioid-Induced Constipation by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid-Induced Constipation Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type: 2026-2031
1.4.2 Methylnaltrexone Bromide
1.4.3 Lubiprostone
1.4.4 Naloxegol
1.4.5 Others
1.5 Market by Application
1.5.1 Global Opioid-Induced Constipation Market Share by Application: 2026-2031
1.5.2 Hospital
1.5.3 Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Overview of Global Opioid-Induced Constipation Market
1.7.1 Global Opioid-Induced Constipation Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS
2.1 Manufacturing Cost Structure Analysis of Opioid-Induced Constipation
2.2 Industry Chain Structure of Opioid-Induced Constipation
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Opioid-Induced Constipation Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Opioid-Induced Constipation Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Opioid-Induced Constipation Average Price by Manufacturers (2020-2025)
4 OPIOID-INDUCED CONSTIPATION REGIONAL MARKET ANALYSIS
4.1 Opioid-Induced Constipation Production by Regions
4.1.1 Global Opioid-Induced Constipation Production by Regions (2020-2025)
4.1.2 Global Opioid-Induced Constipation Revenue by Regions
4.2 Opioid-Induced Constipation Consumption by Regions
4.3 North America Opioid-Induced Constipation Market Analysis
4.3.1 North America Opioid-Induced Constipation Production
4.3.2 North America Opioid-Induced Constipation Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Opioid-Induced Constipation Import and Export
4.4 East Asia Opioid-Induced Constipation Market Analysis
4.4.1 East Asia Opioid-Induced Constipation Production
4.4.2 East Asia Opioid-Induced Constipation Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Opioid-Induced Constipation Import & Export
4.5 Europe Opioid-Induced Constipation Market Analysis
4.5.1 Europe Opioid-Induced Constipation Production
4.5.2 Europe Opioid-Induced Constipation Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Opioid-Induced Constipation Import & Export
4.6 South Asia Opioid-Induced Constipation Market Analysis
4.6.1 South Asia Opioid-Induced Constipation Production
4.6.2 South Asia Opioid-Induced Constipation Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Opioid-Induced Constipation Import & Export
4.7 Southeast Asia Opioid-Induced Constipation Market Analysis
4.7.1 Southeast Asia Opioid-Induced Constipation Production
4.7.2 Southeast Asia Opioid-Induced Constipation Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Opioid-Induced Constipation Import & Export
4.8 Middle East Opioid-Induced Constipation Market Analysis
4.8.1 Middle East Opioid-Induced Constipation Production
4.8.2 Middle East Opioid-Induced Constipation Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Opioid-Induced Constipation Import & Export
4.9 Africa Opioid-Induced Constipation Market Analysis
4.9.1 Africa Opioid-Induced Constipation Production
4.9.2 Africa Opioid-Induced Constipation Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Opioid-Induced Constipation Import & Export
4.10 Oceania Opioid-Induced Constipation Market Analysis
4.10.1 Oceania Opioid-Induced Constipation Production
4.10.2 Oceania Opioid-Induced Constipation Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Opioid-Induced Constipation Import & Export
4.11 South America Opioid-Induced Constipation Market Analysis
4.11.1 South America Opioid-Induced Constipation Production
4.11.2 South America Opioid-Induced Constipation Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Opioid-Induced Constipation Import & Export
5 OPIOID-INDUCED CONSTIPATION SALES MARKET BY TYPE (2020-2031)
5.1 Global Opioid-Induced Constipation Historic Market Size by Type (2020-2025)
5.2 Global Opioid-Induced Constipation Forecasted Market Size by Type (2026-2031)
6 OPIOID-INDUCED CONSTIPATION CONSUMPTION MARKET BY APPLICATION(2020-2031)
6.1 Global Opioid-Induced Constipation Historic Market Size by Application (2020-2025)
6.2 Global Opioid-Induced Constipation Forecasted Market Size by Application (2026-2031)
7 COMPANY PROFILES AND KEY FIGURES IN OPIOID-INDUCED CONSTIPATION BUSINESS
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Company Profile
7.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
7.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Bayer
7.2.1 Bayer Company Profile
7.2.2 Bayer Opioid-Induced Constipation Product Specification
7.2.3 Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Sanofi
7.3.1 Sanofi Company Profile
7.3.2 Sanofi Opioid-Induced Constipation Product Specification
7.3.3 Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Mallinckrodt
7.4.1 Mallinckrodt Company Profile
7.4.2 Mallinckrodt Opioid-Induced Constipation Product Specification
7.4.3 Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Salix (Bausch Health)
7.5.1 Salix (Bausch Health) Company Profile
7.5.2 Salix (Bausch Health) Opioid-Induced Constipation Product Specification
7.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 AstraZeneca
7.6.1 AstraZeneca Company Profile
7.6.2 AstraZeneca Opioid-Induced Constipation Product Specification
7.6.3 AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Progenics Pharmaceuticals
7.7.1 Progenics Pharmaceuticals Company Profile
7.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
7.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Purdue Pharm
7.8.1 Purdue Pharm Company Profile
7.8.2 Purdue Pharm Opioid-Induced Constipation Product Specification
7.8.3 Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Nektar Therapeutics
7.9.1 Nektar Therapeutics Company Profile
7.9.2 Nektar Therapeutics Opioid-Induced Constipation Product Specification
7.9.3 Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Company Profile
7.10.2 Daiichi Sankyo Opioid-Induced Constipation Product Specification
7.10.3 Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Prestige
7.11.1 Prestige Company Profile
7.11.2 Prestige Opioid-Induced Constipation Product Specification
7.11.3 Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 GSK
7.12.1 GSK Company Profile
7.12.2 GSK Opioid-Induced Constipation Product Specification
7.12.3 GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 Shionogi
7.13.1 Shionogi Company Profile
7.13.2 Shionogi Opioid-Induced Constipation Product Specification
7.13.3 Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 PRODUCTION AND SUPPLY FORECAST
8.1 Global Forecasted Production of Opioid-Induced Constipation (2026-2031)
8.2 Global Forecasted Revenue of Opioid-Induced Constipation (2026-2031)
8.3 Global Forecasted Price of Opioid-Induced Constipation (2020-2031)
8.4 Global Forecasted Production of Opioid-Induced Constipation by Region (2026-2031)
8.4.1 North America Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.3 Europe Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.7 Africa Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.9 South America Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Opioid-Induced Constipation Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Opioid-Induced Constipation by Application (2026-2031)
9 CONSUMPTION AND DEMAND FORECAST
9.1 North America Forecasted Consumption of Opioid-Induced Constipation by Country
9.2 East Asia Market Forecasted Consumption of Opioid-Induced Constipation by Country
9.3 Europe Market Forecasted Consumption of Opioid-Induced Constipation by Countriy
9.4 South Asia Forecasted Consumption of Opioid-Induced Constipation by Country
9.5 Southeast Asia Forecasted Consumption of Opioid-Induced Constipation by Country
9.6 Middle East Forecasted Consumption of Opioid-Induced Constipation by Country
9.7 Africa Forecasted Consumption of Opioid-Induced Constipation by Country
9.8 Oceania Forecasted Consumption of Opioid-Induced Constipation by Country
9.9 South America Forecasted Consumption of Opioid-Induced Constipation by Country
9.10 Rest of the world Forecasted Consumption of Opioid-Induced Constipation by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES
Key Players Covered: Ranking by Opioid-Induced Constipation Revenue 2020-2025
Global Opioid-Induced Constipation Market Size by Type: 2026-2031
Global Opioid-Induced Constipation Market Size by Application: 2026-2031
Opioid-Induced Constipation Production Rank and Commercial Production Date of Key Manufacturers
Global Opioid-Induced Constipation Manufacturing Plants Distribution and Commercial Production Date
Global Opioid-Induced Constipation Production Capacity by Manufacturers
Global Opioid-Induced Constipation Production by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Production Market Share by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Revenue by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Revenue Share by Manufacturers (2020-2025)
Global Market Opioid-Induced Constipation Average Price of Key Manufacturers (2020-2025)
Manufacturers Opioid-Induced Constipation Production Sites and Area Served
Manufacturers Opioid-Induced Constipation Product Type
Global Opioid-Induced Constipation Production by Regions (2020-2025)
Global Opioid-Induced Constipation Production Market Share by Regions (2020-2025)
Global Opioid-Induced Constipation Revenue by Regions (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Regions (2020-2025)
Global Opioid-Induced Constipation Consumption by Regions (2020-2025)
Global Opioid-Induced Constipation Consumption Market Share by Regions (2020-2025)
Key Opioid-Induced Constipation Players Sales Volume in North America
North America Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in East Asia
East Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Europe
Europe Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in South Asia
South Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Southeast Asia
Southeast Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Middle East
Middle East Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Africa
Africa Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Oceania
Oceania Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in South America
South America Opioid-Induced Constipation Production, Consumption Import and Export
Global Opioid-Induced Constipation Market Size by Type (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Type (2020-2025)
Global Opioid-Induced Constipation Forecasted Market Size by Type (2026-2031)
Global Opioid-Induced Constipation Revenue Market Share by Type (2026-2031)
Global Opioid-Induced Constipation Market Size by Application (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Application (2020-2025)
Global Opioid-Induced Constipation Forecasted Market Size by Application (2026-2031)
Global Opioid-Induced Constipation Revenue Market Share by Application (2026-2031)
Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Opioid-Induced Constipation Production Forecast by Region (2026-2031)
Global Opioid-Induced Constipation Sales Volume Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Volume Market Share Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Revenue Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Revenue Market Share Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Price Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Consumption Volume Forecast by Application (2026-2031)
Global Opioid-Induced Constipation Consumption Value Forecast by Application (2026-2031)
North America Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
East Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Europe Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
South Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Middle East Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Africa Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Oceania Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
South America Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Rest of the world Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Opioid-Induced Constipation Market Share by Type: 2025 VS 2031
Methylnaltrexone Bromide Features
Lubiprostone Features
Naloxegol Features
Others Features
Global Opioid-Induced Constipation Market Share by Application: 2025 VS 2031
Hospital Case Studies
Pharmacy Case Studies
Other Case Studies
Opioid-Induced Constipation Report Years Considered
Global Opioid-Induced Constipation Market Status and Outlook (2020-2031)
North America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
East Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Europe Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Middle East Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Oceania Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Global Opioid-Induced Constipation Revenue (2020-2031)
Global Opioid-Induced Constipation Production Capacity (2020-2031)
Global Opioid-Induced Constipation Production (2020-2031)
Manufacturing Cost Structure Analysis of Opioid-Induced Constipation in 2025
Manufacturing Process Analysis of Opioid-Induced Constipation
Industry Chain Structure of Opioid-Induced Constipation
Global Opioid-Induced Constipation Production Market Share by Regions in 2025
Global Opioid-Induced Constipation Revenue Market Share by Regions in 2025
North America Opioid-Induced Constipation Production Growth Rate 2020-2025
North America Opioid-Induced Constipation Revenue Growth Rate 2020-2025
East Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
East Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Europe Opioid-Induced Constipation Production Growth Rate 2020-2025
Europe Opioid-Induced Constipation Revenue Growth Rate 2020-2025
South Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
South Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Southeast Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
Southeast Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Middle East Opioid-Induced Constipation Production Growth Rate 2020-2025
Middle East Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Africa Opioid-Induced Constipation Production Growth Rate 2020-2025
Africa Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Oceania Opioid-Induced Constipation Production Growth Rate 2020-2025
Oceania Opioid-Induced Constipation Revenue Growth Rate 2020-2025
South America Opioid-Induced Constipation Production Growth Rate 2020-2025
South America Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
Bayer Opioid-Induced Constipation Product Specification
Sanofi Opioid-Induced Constipation Product Specification
Mallinckrodt Opioid-Induced Constipation Product Specification
Salix (Bausch Health) Opioid-Induced Constipation Product Specification
AstraZeneca Opioid-Induced Constipation Product Specification
Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
Purdue Pharm Opioid-Induced Constipation Product Specification
Nektar Therapeutics Opioid-Induced Constipation Product Specification
Daiichi Sankyo Opioid-Induced Constipation Product Specification
Prestige Opioid-Induced Constipation Product Specification
GSK Opioid-Induced Constipation Product Specification
Shionogi Opioid-Induced Constipation Product Specification
Global Opioid-Induced Constipation Production Capacity Growth Rate Forecast (2026-2031)
Global Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Global Opioid-Induced Constipation Price and Trend Forecast (2020-2031)
North America Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
North America Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
East Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
East Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Europe Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Europe Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
South Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
South Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Southeast Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Middle East Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Middle East Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Africa Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Africa Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Oceania Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Oceania Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
South America Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
South America Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Rest of the World Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Rest of the World Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
North America Opioid-Induced Constipation Consumption Forecast 2026-2031
East Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Europe Opioid-Induced Constipation Consumption Forecast 2026-2031
South Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Middle East Opioid-Induced Constipation Consumption Forecast 2026-2031
Africa Opioid-Induced Constipation Consumption Forecast 2026-2031
Oceania Opioid-Induced Constipation Consumption Forecast 2026-2031
South America Opioid-Induced Constipation Consumption Forecast 2026-2031
Rest of the world Opioid-Induced Constipation Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
Key Players Covered: Ranking by Opioid-Induced Constipation Revenue 2020-2025
Global Opioid-Induced Constipation Market Size by Type: 2026-2031
Global Opioid-Induced Constipation Market Size by Application: 2026-2031
Opioid-Induced Constipation Production Rank and Commercial Production Date of Key Manufacturers
Global Opioid-Induced Constipation Manufacturing Plants Distribution and Commercial Production Date
Global Opioid-Induced Constipation Production Capacity by Manufacturers
Global Opioid-Induced Constipation Production by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Production Market Share by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Revenue by Manufacturers (2020-2025)
Global Opioid-Induced Constipation Revenue Share by Manufacturers (2020-2025)
Global Market Opioid-Induced Constipation Average Price of Key Manufacturers (2020-2025)
Manufacturers Opioid-Induced Constipation Production Sites and Area Served
Manufacturers Opioid-Induced Constipation Product Type
Global Opioid-Induced Constipation Production by Regions (2020-2025)
Global Opioid-Induced Constipation Production Market Share by Regions (2020-2025)
Global Opioid-Induced Constipation Revenue by Regions (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Regions (2020-2025)
Global Opioid-Induced Constipation Consumption by Regions (2020-2025)
Global Opioid-Induced Constipation Consumption Market Share by Regions (2020-2025)
Key Opioid-Induced Constipation Players Sales Volume in North America
North America Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in East Asia
East Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Europe
Europe Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in South Asia
South Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Southeast Asia
Southeast Asia Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Middle East
Middle East Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Africa
Africa Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in Oceania
Oceania Opioid-Induced Constipation Production, Consumption Import and Export
Key Opioid-Induced Constipation Players Sales Volume in South America
South America Opioid-Induced Constipation Production, Consumption Import and Export
Global Opioid-Induced Constipation Market Size by Type (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Type (2020-2025)
Global Opioid-Induced Constipation Forecasted Market Size by Type (2026-2031)
Global Opioid-Induced Constipation Revenue Market Share by Type (2026-2031)
Global Opioid-Induced Constipation Market Size by Application (2020-2025)
Global Opioid-Induced Constipation Revenue Market Share by Application (2020-2025)
Global Opioid-Induced Constipation Forecasted Market Size by Application (2026-2031)
Global Opioid-Induced Constipation Revenue Market Share by Application (2026-2031)
Takeda Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Bayer Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Sanofi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Table Mallinckrodt Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Salix (Bausch Health) Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
AstraZeneca Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Progenics Pharmaceuticals Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Purdue Pharm Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Nektar Therapeutics Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Daiichi Sankyo Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Prestige Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
GSK Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Shionogi Opioid-Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2020-2025)
Global Opioid-Induced Constipation Production Forecast by Region (2026-2031)
Global Opioid-Induced Constipation Sales Volume Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Volume Market Share Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Revenue Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Revenue Market Share Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Sales Price Forecast by Type (2026-2031)
Global Opioid-Induced Constipation Consumption Volume Forecast by Application (2026-2031)
Global Opioid-Induced Constipation Consumption Value Forecast by Application (2026-2031)
North America Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
East Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Europe Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
South Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Middle East Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Africa Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Oceania Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
South America Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Rest of the world Opioid-Induced Constipation Consumption Forecast 2026-2031 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2026-2031)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Opioid-Induced Constipation Market Share by Type: 2025 VS 2031
Methylnaltrexone Bromide Features
Lubiprostone Features
Naloxegol Features
Others Features
Global Opioid-Induced Constipation Market Share by Application: 2025 VS 2031
Hospital Case Studies
Pharmacy Case Studies
Other Case Studies
Opioid-Induced Constipation Report Years Considered
Global Opioid-Induced Constipation Market Status and Outlook (2020-2031)
North America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
East Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Europe Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South Asia Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Middle East Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Africa Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Oceania Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
South America Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Rest of the World Opioid-Induced Constipation Revenue (Value) and Growth Rate (2020-2031)
Global Opioid-Induced Constipation Revenue (2020-2031)
Global Opioid-Induced Constipation Production Capacity (2020-2031)
Global Opioid-Induced Constipation Production (2020-2031)
Manufacturing Cost Structure Analysis of Opioid-Induced Constipation in 2025
Manufacturing Process Analysis of Opioid-Induced Constipation
Industry Chain Structure of Opioid-Induced Constipation
Global Opioid-Induced Constipation Production Market Share by Regions in 2025
Global Opioid-Induced Constipation Revenue Market Share by Regions in 2025
North America Opioid-Induced Constipation Production Growth Rate 2020-2025
North America Opioid-Induced Constipation Revenue Growth Rate 2020-2025
East Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
East Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Europe Opioid-Induced Constipation Production Growth Rate 2020-2025
Europe Opioid-Induced Constipation Revenue Growth Rate 2020-2025
South Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
South Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Southeast Asia Opioid-Induced Constipation Production Growth Rate 2020-2025
Southeast Asia Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Middle East Opioid-Induced Constipation Production Growth Rate 2020-2025
Middle East Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Africa Opioid-Induced Constipation Production Growth Rate 2020-2025
Africa Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Oceania Opioid-Induced Constipation Production Growth Rate 2020-2025
Oceania Opioid-Induced Constipation Revenue Growth Rate 2020-2025
South America Opioid-Induced Constipation Production Growth Rate 2020-2025
South America Opioid-Induced Constipation Revenue Growth Rate 2020-2025
Takeda Pharmaceuticals Opioid-Induced Constipation Product Specification
Bayer Opioid-Induced Constipation Product Specification
Sanofi Opioid-Induced Constipation Product Specification
Mallinckrodt Opioid-Induced Constipation Product Specification
Salix (Bausch Health) Opioid-Induced Constipation Product Specification
AstraZeneca Opioid-Induced Constipation Product Specification
Progenics Pharmaceuticals Opioid-Induced Constipation Product Specification
Purdue Pharm Opioid-Induced Constipation Product Specification
Nektar Therapeutics Opioid-Induced Constipation Product Specification
Daiichi Sankyo Opioid-Induced Constipation Product Specification
Prestige Opioid-Induced Constipation Product Specification
GSK Opioid-Induced Constipation Product Specification
Shionogi Opioid-Induced Constipation Product Specification
Global Opioid-Induced Constipation Production Capacity Growth Rate Forecast (2026-2031)
Global Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Global Opioid-Induced Constipation Price and Trend Forecast (2020-2031)
North America Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
North America Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
East Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
East Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Europe Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Europe Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
South Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
South Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Southeast Asia Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Southeast Asia Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Middle East Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Middle East Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Africa Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Africa Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Oceania Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Oceania Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
South America Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
South America Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
Rest of the World Opioid-Induced Constipation Production Growth Rate Forecast (2026-2031)
Rest of the World Opioid-Induced Constipation Revenue Growth Rate Forecast (2026-2031)
North America Opioid-Induced Constipation Consumption Forecast 2026-2031
East Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Europe Opioid-Induced Constipation Consumption Forecast 2026-2031
South Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Southeast Asia Opioid-Induced Constipation Consumption Forecast 2026-2031
Middle East Opioid-Induced Constipation Consumption Forecast 2026-2031
Africa Opioid-Induced Constipation Consumption Forecast 2026-2031
Oceania Opioid-Induced Constipation Consumption Forecast 2026-2031
South America Opioid-Induced Constipation Consumption Forecast 2026-2031
Rest of the world Opioid-Induced Constipation Consumption Forecast 2026-2031
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
